Induction of micronuclei by CsCl in vivo and in vitro

A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins

In vitro genotoxicity testing needs to include tests in both bacterial and mammalian cells, and be able to detect gene mutations, chromosomal damage and aneuploidy. This may be achieved by a combination of the Ames test (detects gene mutations) and the in vitro micronucleus test (MNvit), since the latter detects both chromosomal aberrations and aneuploidy. In this paper we therefore present an analysis of an existing database of rodent carcinogens and a new database of in vivo genotoxins in terms of the in vitro genotoxicity tests needed to detect their in vivo activity. Published in vitro data from at least one test system (most were from the Ames test) were available for 557 carcinogens and 405 in vivo genotoxins. Because there are fewer publications on the MNvit than for other mammalian cell tests, and because the concordance between the MNvit and the in vitro chromosomal aberration (CAvit) test is so high for clastogenic activity, positive results in the CAvit test were taken as indicative of a positive result in the MNvit where there were no, or only inadequate data for the latter. Also, because Hprt and Tk loci both detect gene-mutation activity, a positive Hprt test was taken as indicative of a mouse-lymphoma Tk assay (MLA)-positive, where there were no data for the latter. Almost all of the 962 rodent carcinogens and in vivo genotoxins were detected by an in vitro battery comprising Ames+MNvit. An additional 11 carcinogens and six in vivo genotoxins would apparently be detected by the MLA, but many of these had not been tested in the MNvit or CAvit tests. Only four chemicals emerge as potentially being more readily detected in MLA than in Ames+MNvit--benzyl acetate, toluene, morphine and thiabendazole--and none of these are convincing cases to argue for the inclusion of the MLA in addition to Ames+MNvit. Thus, there is no convincing evidence that any genotoxic rodent carcinogens or in vivo genotoxins would remain undetected in an in vitro test battery consisting of Ames+MNvit.

The toxic function of cesium 5-sulfosalicylate based on the investigation of its trans-erythrocytes membrane behaviors and morphological properties

In order to evaluate the cesium-induced toxic functional changes in organisms, transmembrane activities of cesium 5-sulfosalicylate (Cs(H(2)Ssal)) into human erythrocyte in vitro is presented in this paper, including kinetic characteristic of transport process and pathways involved in it. The uptake amount of Cs(H(2)Ssal) by erythrocyte was determined both by Graphite Furnace Atomic Absorption Spectrometry (GFAAS) and spectrofluorimetry. The pathways of Cs(H(2)Ssal) transporting into erythrocyte are proposed according to inhibition investigation. The influence of Cs(H(2)Ssal) on morphological properties of erythrocytes was examined using Scanning Electron Microscopy (SEM) to determined the endurable concentration extent of erythrocytes to Cs(H(2)Ssal). Results show that transmembrane of Cs(H(2)Ssal) has characteristic of first-order kinetic process during the first 2h, and four pathways were involved in its transporting activities: Ca(2+) channel, Na(+)-K(+) pump, Na(+)-Cs(+) countertransport, and anion Cl(-)/CsCO(3)(-) exchange. The transmembrane process of Cs(H(2)Ssal) can both prevent the uptake of K(+) and induces abnormal accumulation of extracellular K(+) as well as occupy some K(+)-binding sites in protein, causing some tissues losing their activities and functions. Only high concentrations of Cs(H(2)Ssal) could change morphological properties of erythrocytes greatly and cause hemolysis eventually.

Induction of micronuclei in mouse polychromatic erythrocytes by the administration of non-radioactive CsCl by the oral and intraperitoneal route

In the present study, we describe the effects of the concentration and route of administration of non-radioactive cesium chloride (CsCl) in inducing micronuclei in mouse bone marrow polychromatic erythrocytes (PCEs). When the dose of 500mg/kg body weight was administered perorally (p.o.), no significant incidence of micronuclei was detected. However, when the same dose was administered intraperitoneally (i.p.), a significant induction of micronuclei in PCEs was observed compared to control. At the dose of 1000mg/kg, both routes were efficient, with no significant difference in micronucleus frequencies. We conclude that both the p.o. and i.p. routes are efficient in inducing micronuclei, with the i.p. route being more efficient when lower CsCl doses are used.